Delistment of Piperacillin + Tazobactam Preparations in the Government Mediated Access Price (GMAP) List. Click the link to know more regarding the advisory.
Strategic Framework and Implementing Guidelines of the Philippine Medicines Policy 2022-2030
Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.